Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Constipation after hysterectomy: fact or fiction?

E Martinelli1, D F Altomare, M Rinaldi

  • 1Department of Emergency and Organ Transplantation, General Surgery and Liver Transplantation Unit, University Medical School of Bari, Italy.

The European Journal of Surgery = Acta Chirurgica
|July 6, 2000
PubMed
Summary

Hysterectomy can cause constipation due to changes in bowel function. Further research is needed to understand the exact causes and types of constipation following this common surgical procedure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>HER-2</i> gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.

ESMO gastrointestinal oncology·2026
Same author

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026
Same author

Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study.

ESMO gastrointestinal oncology·2026
Same author

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.

ESMO real world data and digital oncology·2026
Same author

Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.

ESMO open·2025

Area of Science:

  • Gynecology
  • Gastroenterology
  • Urology

Background:

  • Hysterectomy frequently leads to postoperative complications, notably urological, sexual, and colorectal issues.
  • Colorectal dysfunction post-hysterectomy manifests as constipation, characterized by delayed transit, infrequent bowel movements, and difficult defecation.

Purpose of the Study:

  • To review existing literature on bowel function modifications after hysterectomy.
  • To explore potential hypotheses, including hormonal changes, iatrogenic factors, and altered recto-vesical sensitivity, contributing to post-hysterectomy constipation.

Main Methods:

  • Literature review of studies investigating bowel function changes after hysterectomy.
  • Analysis of proposed pathogenetic mechanisms for constipation.

Related Experiment Videos

Main Results:

  • Current studies lack clarity on the specific type of constipation (delayed transit vs. obstructed defecation) following hysterectomy.
  • The precise pathogenetic mechanisms underlying these bowel function changes remain unclear.

Conclusions:

  • Significant gaps exist in understanding post-hysterectomy constipation due to a lack of prospective, comparative studies.
  • Controlled prospective research is essential to elucidate the mechanisms and types of constipation after hysterectomy, given its high prevalence.